Search
01/03/2025
INITIATING GLUCOSE MONITORING IN PERSONS WITH TYPE 2 DIABETES MELLITUS. A RANDOMIZED CONTROL TRIAL COMPARING FSL2 VS. CAPILLARY BLOOD GLUCOSE IN TERMS OF TREATMENT SATISFACTION
Mangas, N, Abraldes, N, Martínez, MJ, Figueroa, D, Ramos, M, López, A, Martínez, C, Pujol, I, Mauricio, D, Corcoy, R. INITIATING GLUCOSE MONITORING IN PERSONS WITH TYPE 2 DIABETES MELLITUS. A RANDOMIZED CONTROL TRIAL COMPARING FSL2 VS. CAPILLARY BLOOD GLUCOSE IN TERMS OF TREATMENT SATISFACTION. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025
NON-INVASIVE NEAR-INFRARED SYSTEM FOR SCREENING FOR DIABETES: THE RESULTS FROM ANODE03
Paldánius, PM, Cos, X, Lazaro-Pancheco, D, Salter, J, Mauricio, D. NON-INVASIVE NEAR-INFRARED SYSTEM FOR SCREENING FOR DIABETES: THE RESULTS FROM ANODE03. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025
ASSESSING IMPLEMENTATION OF NOVEL DIABETES SCREENING METHODS ACROSS DIFFERENT CARE DELIVERY SETTINGS
Paldánius, PM, Salter, J, Hernandez, ME, Tipo, B, Franch, J, Cos, X, Mauricio, D. ASSESSING IMPLEMENTATION OF NOVEL DIABETES SCREENING METHODS ACROSS DIFFERENT CARE DELIVERY SETTINGS. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025
BENEFIT:RISK ASSESSMENT OF A NOVEL NON-INVASIVE SCREENING TOOL: INSIGHTS FROM THE ANODE CLINICAL PROGRAMME
Paldánius, PM, Salter, J, Choudhary, P, Cos, X, Mauricio, D. BENEFIT:RISK ASSESSMENT OF A NOVEL NON-INVASIVE SCREENING TOOL: INSIGHTS FROM THE ANODE CLINICAL PROGRAMME. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025
USER SATISFACTION AND GLYCEMIC OUTCOMES IN PWT1D USING AN INNOVATIVE MICROPUMP: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY
Chico, A, Ampudia-Blasco, FJ, Daín, A, Scheibner, K, Dagenbach, N, Grifoll-Romero, L, Barmaymon, D, Vogt, G, Best, J, Etter, T. USER SATISFACTION AND GLYCEMIC OUTCOMES IN PWT1D USING AN INNOVATIVE MICROPUMP: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/02/2022
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas
Tritos NA, Fazeli PK, McCormack A, Mallea-Gil SM, Pineyro MM, Christ-Crain M, Frara S, Labadzhyan A, Ioachimescu AG, Shimon I, Takahashi Y, Gurnell M, Fleseriu M, Valassi E., Wierman, Margaret E.. Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas. Pituitary. 2022; 25(1)DOI:10.1007/s11102-021-01170-3. PMID:34283370. IF:3.800(Q2/5D).
01/09/2021
Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis.
Calderon-Mediavilla M, Vila-Badia R, Dolz M, Butjosa A, Barajas A, Del Cacho N, Sánchez B, Pardo M, Baños I, Usall J, Ochoa S, Santos, A, Nunez, C, Soler, A.. Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis.. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2021; 30(9)DOI:10.1007/s00787-020-01618-0. PMID:32865655. IF:5.349(Q1/1D).
01/02/2026
Oxytocin levels do not change around a meal and correlate with reward-driven caloric consumption in adults with obesity
Wronski, M, Boutin, R, Sailer, CO, Galbiati, F, Aulinas, A, Muhammed, M, Eddy, KT, Thomas, JJ, Kerem, L, Carter, CS, Nazarloo, S, Davis, JM, Blevins, JE, Holman, K, Gydus, J, Smith, SE, Asanza, E, Plessow, F, Lawson, EA. Oxytocin levels do not change around a meal and correlate with reward-driven caloric consumption in adults with obesity. DIABETES OBESITY & METABOLISM. 2026; 28(2)DOI:10.1111/dom.70340. PMID:41392857. IF:5.700(Q1/2D).
08/01/2026
Assessing the Value of Data-Driven Frameworks for Personalized Medicine in Pituitary Tumours: A Critical Overview
Gil, J, de Pedro-Campos, P, Carrato, C, Jardí-Yanes, P, Marques-Pamies, M, Rodríguez-Lloveras, H, Rueda-Pujol, A, Marcos-Ruiz, J, Martinez-Saez, E, Alvarez, CV, Bernabéu, I, Delgado, E, Lamas, C, Picó, A, Webb, SM, Menéndez, E, Martínez-Hernández, R, Sampedro, M, Aulinas, A, Biagetti, B, Marazuela, M, Valassi, E, Jordà, M, Puig-Domingo, M. Assessing the Value of Data-Driven Frameworks for Personalized Medicine in Pituitary Tumours: A Critical Overview. Machine Learning And Knowledge Extraction. 2026; 8(1)DOI:10.3390/make8010016. PMID:. IF:(Q/D).
01/01/2026
Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans
Galbiati, F, Plessow, F, Plummer, L, Campbell, MB, Nazarloo, S, Carter, CS, Davis, JM, Miller, KK, Carroll, RS, Kaiser, UB, Seminara, SB, Aulinas, A, Lawson, EA. Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans. JOURNAL OF NEUROENDOCRINOLOGY. 2026; 38(1)DOI:10.1111/jne.70114. PMID:41273106. IF:4.100(Q1/3D).
01/11/2025
Consensus on acromegaly therapeutic outcomes: an update
Melmed, S, di Filippo, L, Fleseriu, M, Mercado, M, Karavitaki, N, Gurnell, M, Salvatori, R, Tsagarakis, S, Losa, M, Maffei, P, Pereira, AM, Geer, EB, Katznelson, L, van der Lely, AJ, Bollerslev, J, Esposito, D, Webb, SM, Zatelli, MC, Valassi, E, Neggers, S, Chanson, P, Ho, KKY, Ioachimescu, AG, Biller, BMK, Samson, SL, Kaiser, UB, Schilbach, K, Luque, RM, Casanueva, FF, Shimon, I, Boguszewski, CL, Biermasz, N, Colao, A, Pirchio, R, Lamberts, SWJ, Kadioglu, P, Buchfelder, M, Frara, S, Chiloiro, S, Petersenn, S, Gadelha, MR, Puig-Domingo, M, Luger, A, Brue, T, Beckers, A, Ferone, D, Clemmons, DR, Greenman, Y, Marazuela, M, Mortini, P, Strasburger, CJ, Giustina, A. Consensus on acromegaly therapeutic outcomes: an update. Nature Reviews Endocrinology. 2025; 21(11)DOI:10.1038/s41574-025-01148-2. PMID:40804505. IF:40.000(Q1/1D).
29/05/2025
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly
Martel-Duguech, L, Bascuñana, H, Cuartero, J, Webb, SM, Valassi, E. Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly. Pituitary. 2025; 28(3)DOI:10.1007/s11102-025-01539-8. PMID:40442526. IF:3.400(Q2/4D).
01/01/2024
Comparative Study Of The Effectiveness Of Vedolizumab Versus Ustekinumab After Anti-Tnf Failure In Crohn's Disease (Versus-Cd): Data From Eneida Registry.
García MJ, Rivero M, Fernández-Clotet A, de Francisco R, Sicilia B, Mesonero F, de Castro ML, Casanova MJ, Bertoletti F, García-Alonso FJ, López-García A, Vicente R, Calvet X, Barreiro-de Acosta M, Ferrer Rosique J, Varela Trastoy P, Nuñez A, Ricart E, Riestra S, Arias García L, Rodríguez M, Arranz L, Pajares R, Mena R, Calafat M, Camo P, Bermejo F, Ponferrada Á, Madrigal RE, Llaó J, Sesé E, Sánchez E, Pineda Mariño JR, González Muñoza C, Carbajo López AY, Julián AB, Villoria Ferrer A, Baston-Rey I, Jara L, Almela P, Codesido L, de la Maza S, Leal C, Caballol B, Pérez-Martínez I, Vinuesa Campo R, Crespo J, Domènech E, Chaparro M, Gisbert JP. Comparative Study Of The Effectiveness Of Vedolizumab Versus Ustekinumab After Anti-Tnf Failure In Crohn's Disease (Versus-Cd): Data From Eneida Registry.. Journal of Crohns & Colitis. 2024; 18(1)DOI:10.1093/ecco-jcc/jjad124. PMID:37522878. IF:8.700(Q1/1D).
01/12/2023
Management of small subepithelial tumors by endoscopic banding without resection and single-incision needle-knife-assisted biopsy sampling: a prospective multicenter study.
Bas-Cutrina F, Loras C, Pardo A, Ballester-Clau R, Huertas C, Guarner-Argente C, Colan-Hernandez J, Consiglieri CF, Andujar X, Vilanova-Serra M, González-Huix F, Pardo-Grau L, Maisterra S, Ruiz-Ramírez P, Garcia-Sumalla A, Tebé C, Videla S, Gornals JB. Management of small subepithelial tumors by endoscopic banding without resection and single-incision needle-knife-assisted biopsy sampling: a prospective multicenter study.. GASTROINTESTINAL ENDOSCOPY. 2023; 98(6)DOI:10.1016/j.gie.2023.05.057. PMID:37263361. IF:6.700(Q1/2D).
01/10/2023
Endoscopic Vacuum Therapy for Upper Gastrointestinal Leaks and Perforations: Analysis From a Multicenter Spanish Registry.
Momblan D, Gimeno Garcia AZ, Busquets D, Juzgado D, García Lledó J, Ferrero E, Tejedor-Tejada J, Junquera F, Díaz-Tasende J, Moris M, Rodriguez de Santiago E, Gornals J, Garrido C, Gonzalez-Vazquez S, Guarner-Argente C, Repiso A, Esteban JM, Loras C, Seoane A, Fernández-Simon A, Guevara HC, Ibarzabal A, Morales X, Curell A, Cardenas A, Ríos J, de Lacy AM, Sendino O. Endoscopic Vacuum Therapy for Upper Gastrointestinal Leaks and Perforations: Analysis From a Multicenter Spanish Registry.. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2023; 118(10)DOI:10.14309/ajg.0000000000002475. PMID:37606066. IF:8.500(Q1/1D).
01/02/2026
Predictors of early immunosuppression at ulcerative colitis onset in the biological era
Piñero, G, Castillo, E, González-Muñoza, C, Calm, A, Pujol, C, Gordillo, J, Calafat, M, Bertoletti, F, Garcia-Planella, E, Mañosa, M, Domènech, E. Predictors of early immunosuppression at ulcerative colitis onset in the biological era. Gastroenterologia y Hepatologia. 2026; 49(2)DOI:10.1016/j.gastrohep.2025.502533. PMID:40680924. IF:1.900(Q3/7D).
01/01/2026
Clinical, endoscopic and histological characteristics of Chlamydia trachomatis proctitis in males
Teller, M, Giordano, A, González-Munoza, C, Gordillo, J, Bertoletti, F, Sánchez-Reus, F, Garcia-Planella, E. Clinical, endoscopic and histological characteristics of Chlamydia trachomatis proctitis in males. Gastroenterologia y Hepatologia. 2026; 49(1)DOI:10.1016/j.gastrohep.2025.502558. PMID:40930415. IF:1.900(Q3/7D).
01/01/2026
Impact of Multiple Sclerosis on the course of Inflammatory Bowel Disease: The MULTIPLEII case-control study from the Young Group of GETECCU
Ramos, CR, Sard, MC, Carballo-Folgoso, L, Ruiz-Rodríguez, J, Moya, MIC, Teller, M, Clotet, AF, Cortés, IL, San Martín, LZ, Moreno, CO, Rivas, C, Cuellar, MA, Elorza, A, Gisbert, J, Martinez, MR, Poceiro, JC, Brunet, E, Caravaca, C, Rey, IB, Piñero, GS, Diaz, AP, Orenga, C, Carrilloramos, MJ, Montero, MG, Sandoval, CT, Velázquez, LM, Olmedo-Martín, R, Catalá, AC, Alonso,, Molina, IGDL, Molina, F, Salmón, P, Giordano, A, Moranta, FR, Zabana, Y, Planella, EG. Impact of Multiple Sclerosis on the course of Inflammatory Bowel Disease: The MULTIPLEII case-control study from the Young Group of GETECCU. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.1197. PMID:. IF:8.700(Q1/1D).
01/01/2026
Prevalence, clinical characterisation and therapeutic outcomes of non-fistulising perianal lesions in Crohn's disease (ULCERS-CD): Results from the ENEIDA registry of GETECCU
Casanova, MJ, Garcia, RMD, Ramos, CL, Camba, AH, Gargayo-Puyuelo, C, Senosiain, BC, Gismero, FM, Pagola, L, Cruañas, AA, Giordano, A, Diaz, AP, Velázquez, LM, Robledo-Andrés, P, Regueiro, C, Gonzalez, MS, Jara, RA, Santos, DC, Glaría, EB, Marquès-Camí, M, Trastoy, PV, Acosta, MBD, de la Osa, DR, Luque, RS, Teller, M, De Célix, CR, Almela, P, Font-Ordeig, G, Bujanda, L, Orenga-Sánchez, C, Oliveras-Font, B, Alvarez, PGI, Sánchez, RM, Guillena, PGD, Arce, NM, Martinez, IP, Alonso, FJG, Ramos, CR, Moral, ED, Chaparro, M, Gisbert, J. Prevalence, clinical characterisation and therapeutic outcomes of non-fistulising perianal lesions in Crohn's disease (ULCERS-CD): Results from the ENEIDA registry of GETECCU. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.960. PMID:. IF:8.700(Q1/1D).
01/01/2026
Comparative study on the effectiveness, durability, and safety of upadacitinib versus risankizumab after anti-TNF failure in Crohn's Disease: The U-PARIS study of ENEIDA
De Célix, CR, Granja, A, Iborra, M, Alonso, FJG, Vela, M, de Castro, L, García-Sola, C, Barrero, S, Trastoy, PV, Andrés, PR, Riestra, S, Diaz, AP, Santos, DC, Camps, B, Gisbert, J, García, MJ, Palomares, MTDL, Lozano, OM, de la Cruz, DR, López, E, Pascual, CM, Izquierdo, S, Flores, EI, Iglesias, RF, Argüelles-Arias, F, Martin, D, Ramírez, MAR, Villaamil, PV, Martinez, AMT, Ramos, CR, Velázquez, LM, Ciria, MM, Brunet, E, Zabana, Y, Villarroya, RP, Altadill, A, Moral, ED, Mateu, PN, Acosta, MBD, San Jose, FB. Comparative study on the effectiveness, durability, and safety of upadacitinib versus risankizumab after anti-TNF failure in Crohn's Disease: The U-PARIS study of ENEIDA. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.069. PMID:. IF:8.700(Q1/1D).
01/01/2026
Safety of biologic and small molecule therapies in IBD patients with previous cancer: risk of recurrence or new neoplasia
Calvo, M, Fernández-Felix, BM, Jiménez, IO, Guardia, JL, Menéndez, SR, Gismero, FM, Parga, MLD, Trastoy, PV, Vela, M, Carrasco, NM, Gargallo-Puyuelo, C, Ramos, CR, Arranz, MDM, Rivas, C, Capón, JG, Garcia, LA, Casbas, AG, San Jose, FB, Gonzalez, S, Lucia, M, Elorza, A, Sepulcre, MFG, Fernández-Salazar, L, Mínguez, A, Quiñones, M, Taxonera, C, Barreiro-de Acosta, M, Diaz, AP, Flores, EI, Cano, MP, Sese, E, Casals, DB, Bas-Cutrina, F, Glaría, EB, Moreno, AZG, Poceiro, JC, Lopez, LR, Moral, ED, Chaparro, M, Gisbert, J. Safety of biologic and small molecule therapies in IBD patients with previous cancer: risk of recurrence or new neoplasia. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.897. PMID:. IF:8.700(Q1/1D).
01/01/2026
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA
de Célix, CR, Ricart, E, Martín-Arranz, MD, de Francisco, R, García-Alonso, FJ, Mesonero, F, Gomollón, F, de Castro, L, Ramos, L, García-López, S, Arias, L, Mañosa, M, Iglesias, E, Calvet, X, Bolufer, CS, Casanova, MJ, Pérez-Calle, JL, Giordano, A, Sierra-Ausín, M, Vera, I, Navarro-Llavat, M, Lorente, R, Piqueras, M, Rivero, M, Guardiola, J, Esteve, M, Coronel, AF, Rodríguez-Lago, I, Ponferrada-Díaz, A, Ber, Y, Tardillo, C, Márquez, L, Carpio, D, Taxonera, C, Bermejo, F, Busquets, D, Camps, B, Gutiérrez, A, García-Sepulcre, MF, Barreiro-de Acosta, M, Marín-Jiménez, I, Huguet, JM, Fernández-Salazar, LI, Jaó, J, Rodríguez-Gutiérrez, C, Martinez-Flores, C, Bujanda, L, Lucendo, AJ, Sesé, E, Andrés, PR, Ginard, D, Vega, P, Riera, J, Pajares, R, Van Domselaar, M, Almela, P, Pérez, TM, Muñoz-Villafranca, C, Varela, P, Argüelles-Arias, F, Nos, P, Alcaín, G, Hernández, L, Fernández, H, Muñoz, F, Gilabert, P, Navas-López, VM, de la Piscina, PR, Sánchez, LB, Gil, JL, Valldosera, G, Muñoz, RA, Frago, S, Domènech, E, Chaparro, M, Gisbert, JP. Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; 63(1)DOI:10.1111/apt.70312. PMID:40778752. IF:6.700(Q1/1D).
01/01/2026
Small bowel capsule endoscopy and ileocolonoscopy for activity grading in ileal Crohn's disease, a comparative analysis. Results from the CAPITER study, a multicenter study from the Young GETECCU Group
Marquès-Camí, M, Vergés, L, Gonzalez, AE, Huguet, JM, Mateos, AMC, Caravaca, C, Molina, IGD, Suárez, C, Carballo-Folgoso, L, Vivo, MG, Cuadro, CP, Vicente, GT, Martin, MDCL, Ramos, CR, Jimenez, BV, Clotet, AF, Sandoval, CT, Torres, VM, Intriago, AC, Brunet, E, Martín, J, Marin, CAT, Medina, LT, Lozano, OM, Mínguez, A, Velázquez, LM, Sard, MC, Zabana, Y. Small bowel capsule endoscopy and ileocolonoscopy for activity grading in ileal Crohn's disease, a comparative analysis. Results from the CAPITER study, a multicenter study from the Young GETECCU Group. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.468. PMID:. IF:8.700(Q1/1D).
01/01/2026
Clinical and biological factors as predictors of mucosal healing in moderate ulcerative colitis treated with steroids
Ciria, MM, Guardia, JL, Piñero, GS, Sard, MC, Arranz, EM, Zabana, Y, Llavat, MN, Teller, M, Planella, EG, Casals, DB, Miquel, DM, Juan-Ramón, P, Casbas, AG, Ferrer, AV, Viso, LAM, Paz, GB, Alonso, FJG, Tirado, MR, Chaparro, M, Menéndez, SR, Ochoa, OM, Rodríguez-Lago,, Acosta, MBD, Rodríguez-Fortúnez, P, Moral, ED. Clinical and biological factors as predictors of mucosal healing in moderate ulcerative colitis treated with steroids. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.463. PMID:. IF:8.700(Q1/1D).
01/01/2026
Feasibility and safety of endoscopic submucosal dissection In inflammatory bowel disease (ESDEUR-IBD): an European retrospective study
García, MJ, Fraile, M, Katinios, G, Gubbiotti, A, Argyriou, K, Neri, B, Gonzalez, AE, Partida, IG, Gavric, A, Loly, JP, Parga, MLD, Fousekis, F, Quintana, LC, Suchanek, S, Caron, B, Guardia, JL, Terán, A, Abalos, JG, Poortmans, PJ, Hernández, LA, García, AL, Santos, DC, Pallares, PD, Elorza, A, Lopez, LR, Bednarska, O, Savarino, E, Manolakis, A, Mancone, R, Albéniz, E, de Frutos, D, Vieujen, S, Jesús, ARD, Skamnelos, A, Schaefer, M, Ribas, AM, Truyens, M, Romero, DG, López, RH, Tirado, MR. Feasibility and safety of endoscopic submucosal dissection In inflammatory bowel disease (ESDEUR-IBD): an European retrospective study. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.1281. PMID:. IF:8.700(Q1/1D).
01/01/2026
Prevalence and Determinants of Anal and Oral Human Papillomavirus Infection in Men with Inflammatory Bowel Disease: Interim Results from the PAPIMALE Study
Giordano, A, Szafranska, J, Abalos, JG, Muñoza, CG, Vila, CG, Bertoletti, F, Gomez, ER, Planella, EG. Prevalence and Determinants of Anal and Oral Human Papillomavirus Infection in Men with Inflammatory Bowel Disease: Interim Results from the PAPIMALE Study. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.1512. PMID:. IF:8.700(Q1/1D).
01/01/2026
SHORT-TERM HUMAN ALBUMIN THERAPY IMPROVES SERUM SODIUM CONCENTRATION AND REDUCES MORTALITY IN PATIENTS WITH CIRRHOSIS AND DILUTIONAL HYPONATREMIA
Juanola, A, Moreta, M, Sole, C, Pérez-Guasch, M, Ginès, JG, Soria, A, Cuyas, B, Martin-Llahi, M, Ma, A, Pompili, E, Amorós, M, Cruceta, A, Diestro, S, Domenech, G, Rios, J, Sánchez, J, Fabrellas, N, Graupera, I, Pose, E, Gines, P. SHORT-TERM HUMAN ALBUMIN THERAPY IMPROVES SERUM SODIUM CONCENTRATION AND REDUCES MORTALITY IN PATIENTS WITH CIRRHOSIS AND DILUTIONAL HYPONATREMIA. HEPATOLOGY. 2026; 83(1)DOI:. PMID:. IF:15.800(Q1/1D).
01/01/2026
Clinical outcomes in the implementation of peroral endoscopic myotomy (POEM): Results from the Spanish multicenter registry
Estremera-Arevalo, F, Bravo-Meléndez, S, Hijos-Mallada, G, Guarner-Argente, C, Murzi, M, Rodriguez-Santiago, E, de Tejada, AH, Uchima-Koecklin, H, Miranda-Garcia, P, Barquero-Declara, D, Riesco-López, JM, De Maria-Pallarés, P, Fernández-Esparrach, MG, Sánchez-Yagüe, A, Aresté-Anduaga, I, Gonzalez-Gete, G, Sanchez-Vegazof, CT, Penas-Garcia, B, Parejo-Carbonell, S, Martinez-Sánchez, A, Rojo, E, Mata-Bilbao, A, Araujo, IK, Montori, S, Gómez, M, Albeniz, E. Clinical outcomes in the implementation of peroral endoscopic myotomy (POEM): Results from the Spanish multicenter registry. Gastroenterologia y Hepatologia. 2026; 49(1)DOI:10.1016/j.gastrohep.2025.502527. PMID:40769466. IF:1.900(Q3/7D).
01/12/2025
Incidence and Survival of Colorectal Cancer in the United Kingdom From 2000 to 2021: A Population-Based Cohort Study
Pedregal-Pascual, P, Guarner-Argente, C, Tan, EH, Golozar, A, Duarte-Salles, T, Rosen, AW, Delmestri, A, Man, WY, Burn, E, Prieto-Alhambra, D, Newby, D. Incidence and Survival of Colorectal Cancer in the United Kingdom From 2000 to 2021: A Population-Based Cohort Study. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2025; 120(12)DOI:10.14309/ajg.0000000000003460. PMID:40167184. IF:7.600(Q1/1D).
28/11/2025
Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis
Langtry, A, Rabadan, R, Alonso, L, Filip, I, Sabroso-Lasa, S, Moreno-Oya, A, Lawlor, R, Carrato, A, Alvarez-Gallego, R, Iglesias, M, Molero, X, Löhr, MJ, Michalski, CW, Perea, J, O'Rorke, M, Barberà, VM, Tardon, A, Farré, A, Muñoz-Bellvís, L, Crnogorac-Jurcevic, T, Domínguez-Muñoz, E, Gress, TM, Greenhalf, W, Sharp, L, Balsells, J, Costello, E, Kleeff, J, Kong, B, Mora, J, O'Driscoll, D, Scarpa, A, Ye, WM, Real, FX, de Maturana, EL, Malats, N, Gomez-Rubio, P, Molina-Montes, E, Márquez, M, Milne, R, Alfaro, A, Lobato, T, Estudillo, L, Beghelli, S, Cubillo, A, Hidalgo, M, Peinado, P, Salas, I, Pascual, JR, Earl, J, Caminoa, A, Guillén-Ponce, C, Rodríguez-Garrote, M, Longo-Muñoz, F, Ferreiro, R, Pachon, V, Vaz, MA, Muñoz, M, Ilzarbe, L, Alvarez-Urturi, C, Bessa, X, Bory, F, Márquez, L, Poves, I, Burdío, F, Grande, L, Gimeno, J, Guarner, L, Balcells, J, Salcedo, M, Merino, X, Esposito, I, Mota, C, Huang, JQ, Verbeke, C, Yu, JR, Loinaz, C, Rodríguez-Peralto, JL, Teijo, A, Peláez, P, Martín, M, Artigas, V, Guarner, C, Sancho, FJ, Concepcion, M, Cajal, TRY, Szafranska, J, Murray, L, Cantwell, M, Gallego, J, Barneo, L, Rodriguez-Suarez, M, Pazos, Y, Lozano, A, Luaces, M, Blanco-Antona, F, Manzano, JMS, Troncoso, MLG, de Matos, AO, Buchholz, M, Neesse, A, Kocher, HM, Bhattacharya, S, Abraham, AT, Ennis, D, Dowe, T, Radon, T. Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-65811-y. PMID:41315260. IF:15.700(Q1/1D).
01/09/2025
THE HOME CARE SERVICE IN BARCELONA AS A MODEL FOR COMMUNITY-BASED CARE SERVICES: A QUALITATIVE APPROACH
Macaya, I, Ollé, L, Sánchez, E, Pérez, M, Borrell, C, Pérez, K. THE HOME CARE SERVICE IN BARCELONA AS A MODEL FOR COMMUNITY-BASED CARE SERVICES: A QUALITATIVE APPROACH. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
22/01/2025
Effectiveness and safety of upadacitinib in ulcerative colitis in clinical practice: results from the U-REAL-UC study from ENEIDA
Chaparro, M, Hermida, S, Martín, LZS, Cuquerella, JT, de Castro, L, Domínguez, CL, Rodríguez-Lago, I, Castro, CR, Trastoy, PV, Gargallo-Puyuelo, CJ, Abadía, PR, Ruiz-Cerulla, A, Acosta, MBD, de Francisco, R, Gutiérrez, A, Jiménez, N, Villarroya, RP, Bujanda, L, Martínez, AMT, García, LA, Camero, RC, Calafat, M, Palomares, MTDL, Andrés, PR, Sampedro, MJ, Nieto, YB, Bermejo, F, Moya, MC, Casanova, MJ, Ceballos, D, Martín-Rodríguez, D, Mesonero, F, Zabana, Y, Crespo, AS, Sierra-Ausín, M, Caballol, B, Luengo, MC, Giordano, A, Domènech, E, Gisbert, JP, U REAL UC Study Grp ENEIDA. Effectiveness and safety of upadacitinib in ulcerative colitis in clinical practice: results from the U-REAL-UC study from ENEIDA. Journal of Crohns & Colitis. 2025; 19DOI:10.1093/ecco-jcc/jjae190.0838. PMID:. IF:8.700(Q1/1D).
22/01/2025
Comparative analysis between capsule endoscopy and ileocolonoscopy for activity detection in ileal Crohn's disease. Preliminary results from the CAPITER study, a multicenter study from the Young Group of GETECCU
Marquès-Cami, M, Vergés, L, Caballero-Mateos, AM, Carvaca, C, Suárez-Ferrer, C, Carballo-Folgoso, L, Carballal, A, Roig, C, Fernández-Clotet, A, Moreno,, Tejido, C, Brunet-Mas, E, Torres, G, Huguet, JM, San-Román, C, Benítez, JM, Zabana, Y, Young Grp GETECCU. Comparative analysis between capsule endoscopy and ileocolonoscopy for activity detection in ileal Crohn's disease. Preliminary results from the CAPITER study, a multicenter study from the Young Group of GETECCU. Journal of Crohns & Colitis. 2025; 19DOI:10.1093/ecco-jcc/jjae190.0609. PMID:. IF:8.700(Q1/1D).
22/01/2025
Comparing JAK inhibitors in ulcerative colitis: which one truly leads in the real world? Results from the ENEIDA registry of GETECCU
Chaparro, M, Hermida, S, Camero, RC, Abadía, PR, Vela-González, M, Casanova, MJ, de Castro, L, Gargallo-Puyuelo, CJ, García, LA, de Francisco, R, San Martín, LZ, Barreiro-de Acosta, M, Cuquerella, JT, Lago, IR, Moya, MC, Domínguez, CL, Villarroya, RP, Andrés, PR, Calafat, M, Gutiérrez, A, Pascual, CM, Crespo, AS, Caballol, B, Sierra-Ausín, M, Poceiro, JC, Giordano, A, Huguet, JM, Manzano, MAM, Castro, CR, Ruiz-Cerulla, A, Almela, P, Martínez, AMT, Senosiain, BC, Flores, EI, Martín-Rodríguez, D, Trastoy, PV, Ceballos, D, Palomares, MTDL, Domènech, E, Gisbert, JP, SET UP UC Study Grp GETECCU. Comparing JAK inhibitors in ulcerative colitis: which one truly leads in the real world? Results from the ENEIDA registry of GETECCU. Journal of Crohns & Colitis. 2025; 19DOI:10.1093/ecco-jcc/jjae190.0866. PMID:. IF:8.700(Q1/1D).
01/01/2025
Translation and validation of the IBD-Disk as a tool for assessing the degree of disability in a cohort of Spanish-speaking patients with inflammatory bowel disease. TRAVIDI study.
Muñoza, CG, Giordano, A, Gely, C, Abalos, JG, Bertoletti, F, Roig, C, Planella, EG. Translation and validation of the IBD-Disk as a tool for assessing the degree of disability in a cohort of Spanish-speaking patients with inflammatory bowel disease. TRAVIDI study.. Journal of Crohns & Colitis. 2025; 19DOI:. PMID:. IF:8.700(Q1/1D).
01/01/2025
USABILITY OF A TELEMEDICINE PLATFORM FOR CARDIAC TRANSPLANTATION: ACTIVITY, USER INTERACTIONS AND ASSOCIATED FACTORS
Moya, AG, Real, J, de Dios, A, Amorós, P, Ontiveros, G, Gomis, M. USABILITY OF A TELEMEDICINE PLATFORM FOR CARDIAC TRANSPLANTATION: ACTIVITY, USER INTERACTIONS AND ASSOCIATED FACTORS. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
01/10/2021
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Lopez, MG, Chiner-Oms, A, de Viedma, DG, Ruiz-Rodriguez, P, Bracho, MA, Cancino-Munoz, I, D'Auria, G, de Marco, G, Garcia-Gonzalez, N, Goig, GA, Gomez-Navarro, I, Jimenez-Serrano, S, Martinez-Priego, L, Ruiz-Hueso, P, Ruiz-Roldan, L, Torres-Puente, M, Alberola, J, Albert, E, Zaldumbide, MA, Bea-Escudero, MP, Boga, JA, Bordoy, AE, Canut-Blasco, A, Carvajal, A, Eguiluz, GC, Rodriguez, MLC, Costa-Alcalde, JJ, de Toro, M, Peinado, ID, del Pozo, JL, Duchene, S, Fernandez-Pinero, J, Escriva, BF, Cardona, CG, Galan, VG, Jimenez, NG, Crespo, SH, Herranz, M, Lepe, JA, Lopez-Causape, C, Lopez-Hontangas, JL, Martin, V, Martro, E, Beamonte, AM, Ros, MM, Moreno-Munoz, R, Navarro, D, Navarro-Mari, JM, Not, A, Oliver, A, Palop-Borras, B, Grande, MP, Pedrosa-Corral, I, Gonzalez, MCP, Perez-Lago, L, Perez-Ruiz, M, Vazquez, LP, Rabella, N, Rezusta, A, Fonseca, LR, Sanbonmatsu-Gamez, S, Sicilia, J, Soriano, A, Balaguer, MDT, Torres, I, Tristancho, A, Marimon, JM, Coscolla, M, Gonzalez-Candelas, F, Comas, I, Navarro F., Miró E., Fernandez-Cadenas I, Martínez García L., Roig-Cardelles, M.. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant. NATURE GENETICS. 2021; 53(10)DOI:10.1038/s41588-021-00936-6. PMID:34594042. IF:41.376(Q1/1D).
10/08/2021
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 AMeta-analysis
Shankar-Hari, M, Vale, CL, Godolphin, PJ, Fisher, D, Higgins, JPT, Spiga, F, Savovic, J, Tierney, J, Baron, G, Benbenishty, JS, Berry, LR, Broman, N, Cavalcanti, AB, Colman, R, De Buyser, SL, Derde, LPG, Domingo, P, Omar, SF, Fernandez-Cruz, A, Feuth, T, Garcia, F, Garcia-Vicuna, R, Gonzalez-Alvaro, I, Gordon, AC, Haynes, R, Hermine, O, Horby, PW, Horick, NK, Kumar, K, Lambrecht, BN, Landray, MJ, Leal, L, Lederer, DJ, Lorenzi, E, Mariette, X, Merchante, N, Misnan, NA, Mohan, SV, Nivens, MC, Oksi, J, Perez-Molina, JA, Pizov, R, Porcher, R, Postma, S, Rajasuriar, R, Ramanan, AV, Ravaud, P, Reid, PD, Rutgers, A, Sancho-Lopez, A, Seto, TB, Sivapalasingam, S, Soin, AS, Staplin, N, Stone, JH, Strohbehn, GW, Sunden-Cullberg, J, Torre-Cisneros, J, Tsai, LW, van Hoogstraten, H, van Meerten, T, Veiga, VC, Westerweel, PE, Murthy, S, Diaz, JV, Marshall, JC, Sterne, JAC, Pomar V., Benito N., WHO Rapid Evidence Appraisal COVID. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 AMeta-analysis. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2021; 326(6)DOI:10.1001/jama.2021.11330. PMID:34228774. IF:157.375(Q1/1D).
01/12/2021
Mural Endocarditis: The GAMES Registry Series and Review of the Literature
Gutierrez-Villanueva, A, Munoz, P, Delgado-Montero, A, Olmedo-Samperio, M, de Alarcon, A, Gutierrez-Carretero, E, Zarauza, J, Pares, DGI, Goenaga, MA, Ojeda-Burgos, G, Goikoetxea-Agirre, AJ, Reguera-Iglesias, JM, Ramos, A, Fernandez-Cruz, A, Benito N., Spanish Collaboration Endo. Mural Endocarditis: The GAMES Registry Series and Review of the Literature. Infectious Diseases and Therapy. 2021; 10(4)DOI:10.1007/s40121-021-00490-y. PMID:34312819. IF:6.119(Q2/3D).
01/12/2021
Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis
Mitra, S, Jayanti, A, Vart, P, Coca, A, Gallieni, M, Ovrehus, MA, Midtvedt, K, Abd ElHafeez, S, Gandolfini, I, Buttner, S, Franssen, CFM, Hemmelder, MH, Canal C., Facundo C., ERACODA Collaborators. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2021; 36(12)DOI:10.1093/ndt/gfab196. PMID:34129039. IF:7.186(Q1/2D).